Susan L. Garson

2.3k total citations
19 papers, 850 citations indexed

About

Susan L. Garson is a scholar working on Cognitive Neuroscience, Endocrine and Autonomic Systems and Experimental and Cognitive Psychology. According to data from OpenAlex, Susan L. Garson has authored 19 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cognitive Neuroscience, 15 papers in Endocrine and Autonomic Systems and 14 papers in Experimental and Cognitive Psychology. Recurrent topics in Susan L. Garson's work include Sleep and Wakefulness Research (16 papers), Sleep and related disorders (14 papers) and Circadian rhythm and melatonin (14 papers). Susan L. Garson is often cited by papers focused on Sleep and Wakefulness Research (16 papers), Sleep and related disorders (14 papers) and Circadian rhythm and melatonin (14 papers). Susan L. Garson collaborates with scholars based in United States, Japan and China. Susan L. Garson's co-authors include John J. Renger, Anthony L. Gotter, Christopher J. Winrow, Paul J. Coleman, Steven V. Fox, Pamela L. Tannenbaum, Joanne Stevens, C. Meacham Harrell, Duane R. Reiss and Scott M. Doran and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Neuropsychopharmacology.

In The Last Decade

Susan L. Garson

19 papers receiving 828 citations

Peers

Susan L. Garson
Steven V. Fox United States
Prashant Trivedi United States
Frances Jewitt United Kingdom
Jason L. Locke United States
Jaw-Kang Chang United States
Hisao Nishikawa Japan
Taylor A. Gentile United States
Claire M. Scott United Kingdom
J‐L Moreau Switzerland
Guo Chang United States
Steven V. Fox United States
Susan L. Garson
Citations per year, relative to Susan L. Garson Susan L. Garson (= 1×) peers Steven V. Fox

Countries citing papers authored by Susan L. Garson

Since Specialization
Citations

This map shows the geographic impact of Susan L. Garson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Garson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Garson more than expected).

Fields of papers citing papers by Susan L. Garson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Garson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Garson. The network helps show where Susan L. Garson may publish in the future.

Co-authorship network of co-authors of Susan L. Garson

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Garson. A scholar is included among the top collaborators of Susan L. Garson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Garson. Susan L. Garson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gotter, Anthony L., Mark S. Forman, C. Meacham Harrell, et al.. (2016). Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man. Scientific Reports. 6(1). 27147–27147. 67 indexed citations
2.
Roecker, Anthony J., Swati P. Mercer, Jeffrey M. Bergman, et al.. (2015). Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Bioorganic & Medicinal Chemistry Letters. 25(21). 4992–4999. 14 indexed citations
3.
Kuduk, Scott D., Joseph G. Bruno, Mark H. Pausch, et al.. (2015). Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties. Bioorganic & Medicinal Chemistry Letters. 25(12). 2488–2492. 15 indexed citations
4.
Gotter, Anthony L., Susan L. Garson, Joanne Stevens, et al.. (2014). Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators. BMC Neuroscience. 15(1). 109–109. 40 indexed citations
5.
Tannenbaum, Pamela L., Joanne Stevens, Alan T. Savitz, et al.. (2014). Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs. Frontiers in Behavioral Neuroscience. 8. 182–182. 32 indexed citations
6.
Roecker, Anthony J., Swati P. Mercer, C. Meacham Harrell, et al.. (2014). Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis. Bioorganic & Medicinal Chemistry Letters. 24(9). 2079–2085. 9 indexed citations
7.
Raheem, Izzat T., Michael J. Breslin, Joseph G. Bruno, et al.. (2014). Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant. Bioorganic & Medicinal Chemistry Letters. 25(3). 444–450. 17 indexed citations
8.
Fox, Steven V., Anthony L. Gotter, Spencer J. Tye, et al.. (2013). Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats. Neuropsychopharmacology. 38(12). 2401–2408. 33 indexed citations
9.
Gotter, Anthony L., Christopher J. Winrow, Susan L. Garson, et al.. (2013). The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold. BMC Neuroscience. 14(1). 90–90. 76 indexed citations
10.
Ramirez, Andres D., Anthony L. Gotter, Steven V. Fox, et al.. (2013). Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators. Frontiers in Neuroscience. 7. 254–254. 33 indexed citations
11.
Mercer, Swati P., Anthony J. Roecker, Susan L. Garson, et al.. (2013). Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs). Bioorganic & Medicinal Chemistry Letters. 23(24). 6620–6624. 19 indexed citations
12.
Winrow, Christopher J., Anthony L. Gotter, Christopher D. Cox, et al.. (2011). Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia. Neuropharmacology. 62(2). 978–987. 109 indexed citations
13.
Gotter, Anthony L., Joshua Millstein, Susan L. Garson, et al.. (2011). Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross. Journal of Neurogenetics. 25(4). 167–181. 7 indexed citations
14.
Winrow, Christopher J., Anthony L. Gotter, Christopher D. Cox, et al.. (2011). Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist. Journal of Neurogenetics. 25(1-2). 52–61. 218 indexed citations
15.
Coleman, Paul J., John D. Schreier, Anthony J. Roecker, et al.. (2010). Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat. Bioorganic & Medicinal Chemistry Letters. 20(14). 4201–4205. 21 indexed citations
16.
Uebele, Victor N., Anthony L. Gotter, Cindy E. Nuss, et al.. (2009). Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice. Journal of Clinical Investigation. 119(6). 1659–1667. 61 indexed citations
17.
Winrow, Christopher J., Keith Q. Tanis, Duane R. Reiss, et al.. (2009). Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology. 58(1). 185–194. 61 indexed citations
18.
Uebele, Victor N., Cindy E. Nuss, Vincent P. Santarelli, et al.. (2009). T-type calcium channels regulate cortical plasticity in-vivo NR-D-08-7049. Neuroreport. 20(3). 257–262. 15 indexed citations
19.
Wittmann, Marion, Guangping Xu, Michelle Pearson, et al.. (2008). P4‐332: In vivo pharmacodynamic effects of BQCA, a novel selective allosteric M1 receptor modulator. Alzheimer s & Dementia. 4(4S_Part_24). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven V. Fox Breakdown of academic impact, for papers by Prashant Trivedi Breakdown of academic impact, for papers by Frances Jewitt Breakdown of academic impact, for papers by Jason L. Locke Breakdown of academic impact, for papers by Jaw-Kang Chang Breakdown of academic impact, for papers by Hisao Nishikawa Breakdown of academic impact, for papers by Taylor A. Gentile Breakdown of academic impact, for papers by Claire M. Scott Breakdown of academic impact, for papers by J‐L Moreau Breakdown of academic impact, for papers by Guo Chang
Rankless by CCL
2026